The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic implications of lymphangiogenic markers in early-stage NSCLC.
E. Sanmartin
No relevant relationships to disclose
S. Gallach
No relevant relationships to disclose
R. Sirera
No relevant relationships to disclose
C. Hernando
No relevant relationships to disclose
A. Honguero
No relevant relationships to disclose
R. Guijarro
No relevant relationships to disclose
M. Martorell
No relevant relationships to disclose
C. Camps
No relevant relationships to disclose
E. Jantus-Lewintre
No relevant relationships to disclose